GSK3B and cardiac arrhythmia: However, we found SB216763, a GSK-3β inhibitor, nullified the anti-arrhythmic benefits of RLIPC in our rat arrhythmia model, and suppressed RLIPC-induced GSK-3β Ser9 phosphorylation, without affecting GSK-3β Tyr216 phosphorylation.